|
ACSL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.959800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.298030E-01 |
| Normal-vs-Stage2 |
4.296200E-01 |
| Normal-vs-Stage3 |
2.345700E-02 |
| Normal-vs-Stage4 |
5.515900E-02 |
| Stage1-vs-Stage2 |
5.040300E-02 |
| Stage1-vs-Stage3 |
1.956820E-01 |
| Stage1-vs-Stage4 |
2.462400E-01 |
| Stage2-vs-Stage3 |
1.476410E-02 |
| Stage2-vs-Stage4 |
2.593800E-02 |
| Stage3-vs-Stage4 |
8.874200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.908400E-02 |
| Normal-vs-AfricanAmerican |
6.310600E-01 |
| Normal-vs-Asian |
1.021760E-01 |
| Caucasian-vs-AfricanAmerican |
5.439400E-01 |
| Caucasian-vs-Asian |
7.403800E-01 |
| AfricanAmerican-vs-Asian |
4.801200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.437350E-01 |
| Normal-vs-Female |
9.488300E-02 |
| Male-vs-Female |
9.654600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.527600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.176000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.237600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.704000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.013800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.638240E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.570400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.279900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.515000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.301800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.40890000169358E-08 |
| Classical-VS-Follicular |
2.358100E-03 |
| Classical-VS-Other |
8.008500E-02 |
| Classical-VS-Normal |
1.225790E-01 |
| Tall-VS-Follicular |
6.08909589416839E-11 |
| Tall-VS-Other |
7.042000E-01 |
| Tall-VS-Normal |
9.97350002585051E-09 |
| Follicular-VS-Other |
1.464070E-02 |
| Follicular-VS-Normal |
1.790850E-01 |
| Other-VS-Normal |
2.784700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.596600E-01 |
| Normal-vs-N1 |
4.49839999999702E-05 |
| N0-vs-N1 |
1.416640E-04 |
|
|
